| Trait Information | |
| Identifier | MONDO_0002974 |
| Description | A primary or metastatic malignant neoplasm involving the cervix. [NCIT: C9311] | Trait category |
Other trait
|
| Synonyms |
37 synonyms
|
| Child trait(s) | cervical carcinoma |
| Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
|---|---|---|---|---|---|---|
| PGS000073 (CC_Cervix) |
PGP000050 | Graff RE et al. Nat Commun (2021) |
Cervical cancer | cervical carcinoma | 10 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000073/ScoringFiles/PGS000073.txt.gz |
| PGS000784 (CC_Cervix_IV) |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Cervical cancer | cervical carcinoma | 10 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000784/ScoringFiles/PGS000784.txt.gz |
| PGS001299 (GBE_cancer1041) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Cervical cancer | cervical carcinoma | 24 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001299/ScoringFiles/PGS001299.txt.gz |
| PGS003389 (best_CESC) |
PGP000413 | Namba S et al. Cancer Res (2022) |
Cervical cancer | cervical carcinoma | 2,814 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003389/ScoringFiles/PGS003389.txt.gz |
| PGS003428 (Ldpred_CC_170223) |
PGP000435 | Koel M et al. Hum Mol Genet (2023) |
Cervical cancer | cervical carcinoma | 2,894,555 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003428/ScoringFiles/PGS003428.txt.gz | |
| PGS005165 (PRS-CC) |
PGP000711 | Zhu M et al. PLoS Med (2025) |
Cervical cancer | cervical carcinoma | 15 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS005165/ScoringFiles/PGS005165.txt.gz |
| PGS018540 (TPMI_180_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer and dysplasia | cervical cancer | 32 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018540/ScoringFiles/PGS018540.txt.gz | |
| PGS018541 (TPMI_180_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer and dysplasia | cervical cancer | 939,805 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018541/ScoringFiles/PGS018541.txt.gz | |
| PGS018542 (TPMI_180_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer and dysplasia | cervical cancer | 16,145 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018542/ScoringFiles/PGS018542.txt.gz | |
| PGS018543 (TPMI_180_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer and dysplasia | cervical cancer | 983,767 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018543/ScoringFiles/PGS018543.txt.gz | |
| PGS018544 (TPMI_180_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer and dysplasia | cervical cancer | 992,634 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018544/ScoringFiles/PGS018544.txt.gz | |
| PGS018545 (TPMI_180.1_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer | cervical cancer | 1,050 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018545/ScoringFiles/PGS018545.txt.gz | |
| PGS018546 (TPMI_180.1_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer | cervical cancer | 280,778 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018546/ScoringFiles/PGS018546.txt.gz | |
| PGS018547 (TPMI_180.1_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer | cervical cancer | 540,580 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018547/ScoringFiles/PGS018547.txt.gz | |
| PGS018548 (TPMI_180.1_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer | cervical cancer | 983,768 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018548/ScoringFiles/PGS018548.txt.gz | |
| PGS018549 (TPMI_180.1_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Cervical cancer | cervical cancer | 1,011,318 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018549/ScoringFiles/PGS018549.txt.gz |
|
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|---|
| PPM000193 | PGS000073 (CC_Cervix) |
PSS000112| European Ancestry| 226,216 individuals |
PGP000050 | Graff RE et al. Nat Commun (2021) |
Reported Trait: Cervical cancer | OR: 1.22 [1.19, 1.25] | — | — | Genotyping reagent kit (GERA cohort only), genotyping array (UK Biobank only), age, 10 PCs. | Results from meta-analysis of GERA and UKB |
| PPM002039 | PGS000073 (CC_Cervix) |
PSS001012| European Ancestry| 211,795 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |Ext. |
Reported Trait: Incident cervical cancer | HR: 1.22 [1.09, 1.37] | AUROC: 0.745 C-index: 0.75 (0.017) |
— | Age at assessment, genotyping array, PCs(1-15), parity ( ≥1 live birth vs. none), oral contraceptive use (never used (0) vs. <20 years vs. ≥20 years), cigarette pack-years | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
| PPM002055 | PGS000784 (CC_Cervix_IV) |
PSS001012| European Ancestry| 211,795 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Reported Trait: Incident cervical cancer | HR: 1.21 [1.07, 1.35] | AUROC: 0.745 C-index: 0.749 (0.017) |
R²: 0.437 | Age at assessment, genotyping array, PCs(1-15), parity ( ≥1 live birth vs. none), oral contraceptive use (never used (0) vs. <20 years vs. ≥20 years), cigarette pack-years | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
| PPM008992 | PGS001299 (GBE_cancer1041) |
PSS007631| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Cervical cancer | — | AUROC: 0.81923 [0.77827, 0.86018] | R²: 0.1174 Incremental AUROC (full-covars): -0.00507 PGS R2 (no covariates): 0.00206 PGS AUROC (no covariates): 0.46736 [0.35923, 0.57549] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008993 | PGS001299 (GBE_cancer1041) |
PSS007632| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Cervical cancer | — | AUROC: 0.91431 [0.84118, 0.98744] | R²: 0.22017 Incremental AUROC (full-covars): 0.00128 PGS R2 (no covariates): 0.0 PGS AUROC (no covariates): 0.52896 [0.28465, 0.77326] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008994 | PGS001299 (GBE_cancer1041) |
PSS007633| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Cervical cancer | — | AUROC: 0.76761 [0.74661, 0.7886] | R²: 0.11284 Incremental AUROC (full-covars): 0.00676 PGS R2 (no covariates): 0.00263 PGS AUROC (no covariates): 0.55215 [0.51478, 0.58952] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008995 | PGS001299 (GBE_cancer1041) |
PSS007634| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Cervical cancer | — | AUROC: 0.83945 [0.77567, 0.90324] | R²: 0.13265 Incremental AUROC (full-covars): -0.00075 PGS R2 (no covariates): 0.00058 PGS AUROC (no covariates): 0.46169 [0.30956, 0.61382] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM008996 | PGS001299 (GBE_cancer1041) |
PSS007635| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Cervical cancer | — | AUROC: 0.7705 [0.75816, 0.78284] | R²: 0.11652 Incremental AUROC (full-covars): 0.00962 PGS R2 (no covariates): 0.00294 PGS AUROC (no covariates): 0.54769 [0.52291, 0.57247] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
| PPM016264 | PGS003389 (best_CESC) |
PSS010075| European Ancestry| 144,374 individuals |
PGP000413 | Namba S et al. Cancer Res (2022) |
Reported Trait: cervical cancer | — | AUROC: 0.563 | R²: 0.00158 | age, top 20 genetic principal components | — |
| PPM017102 | PGS003428 (Ldpred_CC_170223) |
PSS010125| European Ancestry| 128,113 individuals |
PGP000435 | Koel M et al. Hum Mol Genet (2023) |
Reported Trait: Incident cervical cancer | HR: 1.33 (0.069) | C-index: 0.613 | — | age, smoking | — |
| PPM022403 | PGS005165 (PRS-CC) |
PSS011943| East Asian Ancestry| 57,359 individuals |
PGP000711 | Zhu M et al. PLoS Med (2025) |
Reported Trait: Cervical Cancer | HR: 1.2 [1.06, 1.36] β: 0.182 |
C-index: 0.566 | — | Age,Sex (if applicable),Region,Top 10 genetic ancestry principal components | The HR and C-index values were derived from Cox proportional hazards regression models. |
| PPM036722 | PGS018540 (TPMI_180_Lassosum2) |
PSS012453| East Asian Ancestry| 8,290 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer and dysplasia | — | AUROC: 0.71423 | R²: 0.10406 | sex, age, array, PCs 1-10 | — |
| PPM036723 | PGS018541 (TPMI_180_LDpred2) |
PSS012452| East Asian Ancestry| 8,290 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer and dysplasia | — | AUROC: 0.71373 | R²: 0.10361 | sex, age, array, PCs 1-10 | — |
| PPM036724 | PGS018542 (TPMI_180_MegaPRS) |
PSS012454| East Asian Ancestry| 8,290 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer and dysplasia | — | AUROC: 0.71362 | R²: 0.10344 | sex, age, array, PCs 1-10 | — |
| PPM036725 | PGS018543 (TPMI_180_PRS-CS) |
PSS012455| East Asian Ancestry| 8,290 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer and dysplasia | — | AUROC: 0.7135 | R²: 0.10346 | sex, age, array, PCs 1-10 | — |
| PPM036726 | PGS018544 (TPMI_180_SBayesR) |
PSS012456| East Asian Ancestry| 8,290 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer and dysplasia | — | AUROC: 0.71409 | R²: 0.10359 | sex, age, array, PCs 1-10 | — |
| PPM036727 | PGS018545 (TPMI_180.1_Lassosum2) |
PSS012443| East Asian Ancestry| 8,044 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer | — | AUROC: 0.67978 | R²: 0.02097 | sex, age, array, PCs 1-10 | — |
| PPM036728 | PGS018546 (TPMI_180.1_LDpred2) |
PSS012442| East Asian Ancestry| 8,044 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer | — | AUROC: 0.67992 | R²: 0.02138 | sex, age, array, PCs 1-10 | — |
| PPM036729 | PGS018547 (TPMI_180.1_MegaPRS) |
PSS012444| East Asian Ancestry| 8,044 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer | — | AUROC: 0.67784 | R²: 0.02043 | sex, age, array, PCs 1-10 | — |
| PPM036730 | PGS018548 (TPMI_180.1_PRS-CS) |
PSS012445| East Asian Ancestry| 8,044 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer | — | AUROC: 0.68 | R²: 0.02133 | sex, age, array, PCs 1-10 | — |
| PPM036731 | PGS018549 (TPMI_180.1_SBayesR) |
PSS012446| East Asian Ancestry| 8,044 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cervical cancer | — | AUROC: 0.68346 | R²: 0.02179 | sex, age, array, PCs 1-10 | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS007631 | — | — | [
|
— | African unspecified | — | UKB | — |
| PSS007632 | — | — | [
|
— | East Asian | — | UKB | — |
| PSS007633 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
| PSS007634 | — | — | [
|
— | South Asian | — | UKB | — |
| PSS007635 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
| PSS012442 | 180.0, 180.1, 180.8, 180.9, V10.41,C53 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012443 | 180.0, 180.1, 180.8, 180.9, V10.41,C53 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012444 | 180.0, 180.1, 180.8, 180.9, V10.41,C53 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012445 | 180.0, 180.1, 180.8, 180.9, V10.41,C53 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012446 | 180.0, 180.1, 180.8, 180.9, V10.41,C53 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS011943 | ICD-10: C53 | Median = 11.33 years Range = [10.18, 12.26] years |
[ ,
0.0 % Male samples |
Mean = 53.69 years Sd = 11.01 years |
East Asian (Chinese) |
— | CKB | — |
| PSS012453 | 180, 233.1, 622.1, V10.41,C53, D06, N87 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012452 | 180, 233.1, 622.1, V10.41,C53, D06, N87 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012454 | 180, 233.1, 622.1, V10.41,C53, D06, N87 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012455 | 180, 233.1, 622.1, V10.41,C53, D06, N87 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012456 | 180, 233.1, 622.1, V10.41,C53, D06, N87 | — | [ ,
0.0 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS010125 | C53, D06 | — | [ ,
0.0 % Male samples |
— | European | — | EB | — |
| PSS010075 | C53 | — | [
|
— | European (British) |
— | UKB | Controls were samples without any cancer diagnosis or self-reported cancer |
| PSS001012 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [ ,
0.0 % Male samples |
— | European | — | UKB | — |
| PSS000112 | Cancer diagnoses were obtained from reigstry data in GERA, and ICD-9/10 codes mapped to ICD-O-3 codes in UK Biobank. Cancers for this phenotype were classified using the following SEER site recode(s): 27010 | — | [ ,
0.0 % Male samples |
— | European | — | GERA, UKB | — |